Performance of the Hedrocel(R) Cervical Fusion Device
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The objective of this clinical investigation is to compare patients treated with Anterior Cervical Discectomy and Fusion (ACDF) using the Hedrocel Cervical Fusion Device, with a concurrent, randomized, control group receiving autologous iliac crest bone graft or allograft and test the hypothesis that ACDF with Hedrocel is non-inferior to ACDF with allograft or autologous bone graft.
| Condition | Intervention | Phase |
|---|---|---|
|
Symptomatic Cervical Disc Disease |
Device: Anterior Cervical Discectomy and Fusion |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Performance of the Hedrocel(R) Cervical Fusion Device |
- Overall Clinical Success (NDI, Fusion, Additional Surgical Procedures) [ Time Frame: 12 and 24 Months ] [ Designated as safety issue: Yes ]
- SF-36 [ Time Frame: 12 and 24 Months ] [ Designated as safety issue: No ]
| Enrollment: | 231 |
| Study Start Date: | December 2001 |
| Study Completion Date: | June 2009 |
| Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Experimental Arm 1
Hedrocel
|
Device: Anterior Cervical Discectomy and Fusion
Implantation of Hedrocel
|
|
Experimental: Experimental Arm 2
Hedrocel with a plate
|
Device: Anterior Cervical Discectomy and Fusion
Implantation of Hedrocel
|
|
Experimental: Experimental Arm 3
2 Levels Plated Hedrocel
|
Device: Anterior Cervical Discectomy and Fusion
Implantation of Hedrocel
|
|
Active Comparator: Control Arm 1
Iliac Crest Autograft
|
Device: Anterior Cervical Discectomy and Fusion
Implantation of Autograft
|
|
Active Comparator: Control Arm 2
Plated Autograft
|
Device: Anterior Cervical Discectomy and Fusion
Implantation of Autograft
|
|
Active Comparator: Control Arm 3
Plated Allograft
|
Device: Anterior Cervical Discectomy and Fusion
Implantation of Allograft
|
|
Active Comparator: Control Arm 4
2 Levels with plated Autograft
|
Device: Anterior Cervical Discectomy and Fusion
Implantation of Autograft
|
|
Active Comparator: Control Arm 5
2 Levels with plated Allograft
|
Device: Anterior Cervical Discectomy and Fusion
Implantation of Allograft
|
Detailed Description:
The objective of this clinical investigation is to compare patients treated with Anterior Cervical Discectomy and Fusion (ACDF) using the Hedrocel Cervical Fusion Device, with a concurrent, randomized, control group receiving autologous iliac crest bone graft. Success criteria include radiographic evidence of fusion, and improvement in pain, function and overall quality of life. If shown to be successful, the use of the Hedrocel Cervical Fusion Device would eliminate complications associated with harvesting autologous bone graft and provide an alternative for those who are unable to provide autologous bone graft from the iliac crest.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The patient qualifies for ACDF based upon physical examination and medical history. The patient has single or two adjacent levels(s) symptomatic cervical disc disease (including disc herniation and/or spondylosis) from the C3-C4 disc to the C7-T1 disc with associated radiculopathy and/or myelopathy due to nerve root and/or spinal cord compression due to herniated nucleus pulposus or osteophyte formation on the posterior vertebral endplates. Patients who are candidates for surgery based on radicular symptoms must have at least one month of conservative treatment prior to inclusion in the study.
- The patient has no history of previous anterior cervical fusion surgery at the involved levels.
- The patient has no history of previous cervical fusion surgery at the adjacent levels.
- The patient is willing and able to provide written informed consent.
- The patient is likely to complete the required follow-up.
Exclusion Criteria:
- The patient is mentally compromised (e.g., under treatment for a psychiatric disorder or has senile dementia or Alzheimer's disease), or has evidence of alcohol or other substance abuse for the previous 12 months.
- The patient has a neuromuscular disorder that would engender unacceptable risk of instability, implant fixation failure, or complications in postoperative care.
- The patient has a diagnosed systemic disease that requires the chronic administration of nonsteroidal anti-inflammatory and steroidal drugs.
- The patient has osteopenia to a degree that would contraindicate spinal instrumentation (borderline osteoporosis).
- The patient has osteoporosis to a degree that would contraindicate spinal instrumentation.
- The patient is unable or unwilling to attend postoperative follow-up visits.
- The patient has received an investigational drug within the previous six months or an investigational device within the previous 12 months.
- The patient has a spinal condition other than Cervical DDD based upon physical examination and medical history.
- The patient has an infection site distant from the involved levels that may spread to the involved levels hematogenously.
- The patient has insufficient bone stock to fix the component.
- The patient has a known sensitivity to metallic implants.
- The patient is a prisoner.
- The patient has a Body Mass Index (BMI) greater than or equal to 40.
Contacts and Locations| United States, California | |
| Cedars-Sinai Medical Center Institute for Spinal Disorders | |
| Los Angeles, California, United States, 90048 | |
| United States, Florida | |
| Orthopaedic Specialties | |
| Clearwater, Florida, United States, 33756 | |
| Southeastern Clinic Research | |
| Orlando, Florida, United States, 32804 | |
| United States, Indiana | |
| Fort Wayne Orthopedics | |
| Fort Wayne, Indiana, United States, 46804 | |
| United States, Kentucky | |
| Spine Surgery PSC | |
| Louisville, Kentucky, United States, 40202 | |
| United States, Maryland | |
| Four East Madison Orthopaedic Associates, PA | |
| Baltimore, Maryland, United States, 21204 | |
| United States, Massachusetts | |
| Boston Spine Group, LLC | |
| Boston, Massachusetts, United States, 02120 | |
| United States, Minnesota | |
| Twin Cities Spine Center | |
| Minneapolis, Minnesota, United States, 55404 | |
| United States, North Carolina | |
| Orthocarolina | |
| Charlotte, North Carolina, United States, 28207 | |
| United States, Tennessee | |
| Vanderbilt Orthopedic Institute | |
| Nashville, Tennessee, United States, 37232-8774 | |
| Howell Allen Clinic | |
| Nashville, Tennessee, United States, 37203 | |
| United States, Virginia | |
| University of Virginia Health System - Department of Neurosurgery | |
| Charlottesville, Virginia, United States, 22908 | |
| Inova Fairfax Hospital | |
| Fairfax, Virginia, United States, 22031 | |
More Information
No publications provided
| Responsible Party: | Kristin Jans, Associate Director, Regulatory Affairs, Zimmer, Inc |
| ClinicalTrials.gov Identifier: | NCT00758758 History of Changes |
| Other Study ID Numbers: | IC 003-99 |
| Study First Received: | September 23, 2008 |
| Last Updated: | June 11, 2009 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by Zimmer, Inc.:
|
Anterior Cervical Discectomy and Fusion, Degenerative Disc Disease, Cervical Spine, Herniated Disc |
ClinicalTrials.gov processed this record on June 17, 2013